Vertera Spine said today that the 1st procedures using its Cohere cervical interbody fusion system were performed recently, with a full market release of the device on the horizon.
The Cohere device is composed entirely of Vertera Spine’s novel PEEK Scoria porous biomaterial which the company said is more durable than metal coatings and 2 times stronger under shear loading than trabecular bone.
“I think the porosity of the Cohere PEEK interbody device will allow for more rapid osseointegration seen with textured surface devices, while at the same time allowing for excellent radiographic visualization of the fusion. From the substantial research compiled, we have learned that Scoria’s porosity promotes implant osseointegration with the surface characteristics being more important than the implant material,” Dr. Frank Philips of Chicago’s Rush Univeristy said in prepared remarks. Philips was 1 of the 1st surgeons to perform procedures with Vertera Spine’s devices.
The company’s PEEK Scoria biomaterial is designed to facilitate bone tissue in-growth, featuring a fully interconnected pore network with a wettable surface, which Vertera says bone is able to “infiltrate” and form direct contact with.
“The 1st clinical use of porous PEEK represents a significant milestone for Vertera Spine and can be contributed to the hard work and ingenuity of our entire team. The adoption of Cohere by this initial group of key opinion leaders, along with research support from leading academic institutions, speaks volumes about the impact that Cohere and other implants made with our multifunctional PEEK Scoria biomaterial can have on the spinal fusion market,” CEO Chris Lee.
The Cohere implant is available in multiple footprints and heights with a 7° lordotic angle, and the company is planning a full market release in the coming months.
The post Vertera Spine touts 1st procedures with Cohere spinal fusion device appeared first on MassDevice.